Aurobindo Pharma Stock Falls Nearly 7% In Early Trade After Q2 ResultsShares of Aurobindo Pharma on Monday fell nearly 7 per cent in early trade after the company reported a 41 per cent decline in its consolidated net profit for the second quarter ended September 30,...
